Immix Biopharma, Inc. (IMMX)
↓ Download CSVKey ratios (FY2025)
-31.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$29.96M | -$22.67M | -$16.14M | -$8.22M | -$1.35M | -$453.9K |
| Net Income | -$29.44M | -$21.61M | -$15.43M | -$8.23M | -$24.38M | -$1.15M |
| EPS (Diluted) | $-0.89 | $-0.76 | $-0.89 | $-0.59 | $-6.64 | — |
| Total Assets | $104.84M | $22.95M | $19.93M | $14.91M | $18.19M | $539.6K |
| Total Liabilities | $11.04M | $9.70M | $3.72M | $1.75M | $202.0K | $5.27M |
| Shareholders' Equity | $93.80M | $13.25M | $16.20M | $13.16M | $17.99M | -$4.73M |
| Cash & Equivalents | $93.93M | $17.68M | $17.51M | $13.44M | $17.64M | $391.1K |
| Operating Cash Flow | -$23.93M | -$14.60M | -$11.37M | -$7.41M | -$1.59M | -$404.7K |
| Capital Expenditures | $732.9K | $1.18M | $52.1K | — | $802 | — |
| Shares Outstanding | 52.95M | 27.54M | 19.92M | 13.89M | 13.23M | 3.38M |